Literature DB >> 35031835

NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation.

Cameron J Overfield1, Mark A Edgar2, Daniel E Wessell1, Benjamin K Wilke3, Hillary W Garner4.   

Abstract

Neurotrophic tyrosine receptor kinase (NTRK)-rearranged spindle cell neoplasm is a recently characterized soft tissue tumor and has been classified as provisional by the World Health Organization. Detection of the genetic rearrangement is important because these tumors are amenable to targeted tyrosine kinase inhibitor therapy, which can play a key role in patients with unresectable or advanced disease. Although the spectrum of histopathology associated with this entity is broad, one notable feature is the infiltrative growth pattern, which is most reminiscent of lipofibromatosis-like neural tumor. Description of their diverse histologic attributes has aided recognition, but so far little attention has been paid to correlating the gross appearance and imaging features of these lesions. In this report, we describe the clinical, imaging, histopathological, and genetic features of a soft tissue NTRK-rearranged spindle cell neoplasm. Inclusion of this more recently identified entity into the imaging differential of tumors with intratumoral relatively hypovascular nodules and infiltrative margins is important because testing for NTRK rearrangement is not routinely performed.
© 2022. ISS.

Entities:  

Keywords:  Malignancy; NTRK gene fusion; NTRK-rearranged spindle cell neoplasm; Sarcoma; Soft tissue tumor

Mesh:

Substances:

Year:  2022        PMID: 35031835     DOI: 10.1007/s00256-022-03995-w

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  3 in total

Review 1.  Update on Cutaneous Soft Tissue Tumors.

Authors:  Josephine K Dermawan; Jennifer S Ko; Steven D Billings
Journal:  Surg Pathol Clin       Date:  2021-06

2.  MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value.

Authors:  Hye Jin Yoo; Sung Hwan Hong; Yusuhn Kang; Ja-Young Choi; Kyung Chul Moon; Han-Soo Kim; Ilkyu Han; Minkyong Yi; Heung Sik Kang
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

3.  Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components.

Authors:  Jin Xu; Paul Weisman
Journal:  Genes Chromosomes Cancer       Date:  2020-12-28       Impact factor: 5.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.